HONG KONG, Aug. 9, 2012 /PRNewswire-Asia/ -- Syneron Medical Ltd. (NASDAQ: ELOS), www.syneron.com, the global leader in medical aesthetic products and technology, announced today that, in conjunction with its distribution partner in Thailand, Astraco Medical Network LTD., it has made a donation to the Princess Maha Chakri Sirindhorn Foundation to support victims of the severe monsoon-season flooding that occurred in Thailand in 2011 and continues to impact local communities. The donation to the foundation will help to support recovery in affected areas and provide relief for those impacted by the flooding.
(Logo: http://photos.prnewswire.com/prnh/20120528/535447)
Miguel Pardos, Vice President Asia Pacific of Syneron, on behalf of Astraco Medical Networks Ltd. and its partners, presented the donation to Her Royal Highness Princess Maha Chakri Sirindhorn on July 17, 2012 at Dusidalai Hall, Chitralada Villa, Dusit Palace, the royal family's residence in Bangkok. Mr. Pardos commented, "We offer our condolences to those who have lost loved ones and our thoughts are with all the flood victims. Our sympathies remain with the Thai people at this difficult time."
Louis P. Scafuri, Chief Executive Officer at Syneron, said, "Syneron believes in helping others in need and giving back to the communities in which we live and operate. In particular, we believe in the importance of assisting the Thai people in their long-term flood recovery efforts. We are proud to make this donation in conjunction with our local distribution partner, Astraco Medical Network LTD."
For more information on the Princess Maha Chakri Sirindhorn Foundation and its support of flood victims in Thailand, please visit www.sirindhorn.net.
About Syneron Medical Ltd.
Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. The Company's aspiration and commitment to innovation expands Syneron's offering beyond medical device into the largest in-demand applications in beauty - skin lightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron-candela.com.hk
